评估治疗计划系统中实施的新型CBCT转换方法
本研究在RayStation研究版中评估了一种新型CBCT转换算法用于剂量计算,纳入10例头颈、妇科和肺癌患者,比较CBCTc与CBCTb两种方法相对dCT和pCT的剂量分布一致性。结果显示CBCTc方法的伽马通过率系统性高于CBCTb,差异有统计学意义,剂量偏差主要位于空气/组织交界区及解剖变化区域。
要点
- 以dCT为参考、10%剂量阈值下,CBCTc在头颈和妇科病例的中位GPR分别为100%和99.8%。
- CBCTb在头颈和妇科病例的中位GPR分别为99.8%和98.0%,系统性低于CBCTc。
- 肺癌病例CBCTc与CBCTb的GPR分别为99.9%和97.5%,差异有统计学意义。
核心结论
- 使用新型CBCTc方法计算的剂量分布与dCT和pCT计算的剂量分布表现出极好的一致性,且优于CBCTb方法。
- 计算剂量分布出现偏差的主要原因在于pCT与校正后CBCT之间的解剖变化。
研究设计与样本
- 在RayStation(v. 11B-DTK,RaySearch,斯德哥尔摩,瑞典)研究版治疗计划系统中实施该算法。
- 采集10例头颈(HN)、10例妇科(GYN)和10例肺癌(LNG)患者的CBCT,分别用新算法转换为CBCTc,并与同一版本TPS中的体密度覆盖技术CBCTb进行比较。
- 通过将计划CT(pCT)可变形配准到CBCT生成变形CT(dCT),以减少解剖变化的影响。
- 所有治疗计划在pCT、dCT、CBCTc和CBCTb上重新计算,使用MICE toolkit(NONPIMedical AB,瑞典于默奥)进行局部伽马分析,采用1%剂量差异和1 mm一致性距离标准。
- 采用Wilcoxon配对秩和检验比较伽马通过率(GPR)差异,P值小于0.05认为有统计学意义。
主要发现
- 以dCT为参考、10%剂量阈值下,CBCTc方法在头颈和妇科病例的中位GPR分别为100%和99.8%。
- CBCTb方法在头颈和妇科病例的中位GPR分别为99.8%和98.0%,系统性低于CBCTc。
- 肺癌病例CBCTc与CBCTb方法的GPR分别为99.9%和97.5%,差异有统计学意义。
- CBCT与pCT计算剂量之间的主要差异位于空气/组织交界区附近,这些区域也受解剖变化影响。
关键数值与推荐
- 伽马分析标准为局部伽马分析,采用1%剂量差异和1 mm一致性距离标准。
- 伽马通过率比较采用Wilcoxon配对秩和检验,P值小于0.05认为有统计学意义。
- GPR统计使用10%剂量阈值并以dCT为参考。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: To evaluate a novel CBCT conversion algorithm for dose calculation implemented in a research version of a treatment planning system (TPS). METHODS: The algorithm was implemented in a research version of RayStation (v. 11B-DTK, RaySearch, Stockholm, Sweden). CBCTs acquired for each ten head and neck (HN), gynecology (GYN) and lung cancer (LNG) patients were collected and converted using the new algorithm (CBCTc). A bulk density overriding technique implemented in the same version of the TPS was used for comparison (CBCTb). A deformed CT (dCT) was created by using deformable image registration of the planning CT (pCT) to the CBCT to reduce anatomical changes. All treatment plans were recalculated on the pCT, dCT, CBCTc and the CBCTb. The resulting dose distributions were analyzed using the MICE toolkit (NONPIMedical AB Sweden, Umeå) with local gamma analysis, with 1% dose difference and 1 mm distance to agreement criteria. A Wilcoxon paired rank sum test was applied to test the differences in gamma pass rates (GPRs). A p value smaller than 0.05 considered statistically significant. RESULTS: The GPRs for the CBCTb method were systematically lower compared to the CBCTc method. Using the 10% dose threshold and the dCT as reference the median GPRs were for the CBCTc method were 100% and 99.8% for the HN and GYN cases, respectively. Compared to that the GPRs of the CBCTb method were lower with values of 99.8% and 98.0%, for the HN and GYN cases, respectively. The GPRs of the LNG cases were 99.9% and 97.5% for the CBCTc and CBCTb method, respectively. These differences were statistically significant. The main differences between the dose calculated on the CBCTs and the pCTs were found in regions near air/tissue interfaces, which are also subject to anatomical variations. CONCLUSION: The dose distribution calculated using the new CBCTc method showed excellent agreement with the dose calculated using dCT and pCT and was superior to the CBCTb method. The main reasons for deviations of the calculated dose distribution were caused by anatomical variations between the pCT and the corrected CBCT.
引用
- Lechner W, Kanalas D, Haupt S, et al. Evaluation of a novel CBCT conversion method implemented in a treatment planning system. Radiat Oncol. 2023. PMID: 37974264. doi:10.1186/s13014-023-02378-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。